Indications
Therapeutic Asset Ratings
13,155 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Polatuzumab Vedotin
High Grade B-Cell Lymphoma
Brown University
P2
B
(59)
Pyrotinib
Gastric Cancer
BeOne Medicines
P2
B
(59)
Regramostim
Prostate Cancer
University of Wisconsin, Madison
P2
B
(59)
Relatlimab
Hepatocellular Carcinoma
Bristol-Myers Squibb
P2
B
(59)
Revumenib
Acute Leukemia Of Ambiguous Lineage
SWOG Cancer Research Network
P2
B
(59)
Revumenib
Mixed Phenotype Acute Leukemia
Children's Oncology Group
P2
B
(59)
Riluzole
Cutaneous Melanoma
National Cancer Institute (NCI)
P2
B
(59)
Rituximab
Idiopathic Pulmonary Fibrosis
University of Alabama at Birmingham
P2
B
(59)
Rituximab
Small Cell Lung Carcinoma
Puma Biotechnology, Inc.
P2
B
(59)
Ruxolitinib
Adult T-Cell Leukemia/Lymphoma
Jonathan Brammer
P2
B
(59)
Ruxolitinib
Hematopoietic And Lymphoid System Neoplasm
Stanford University
P2
B
(59)
Ruxolitinib
Non-Hodgkin Lymphoma
Seda S. Tolu
P2
B
(59)
Ruxolitinib
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
St. Petersburg State Pavlov Medical University
P2
B
(59)
Ruxolitinib
Myelofibrosis
Center for International Blood and Marrow Transplant Research
P2
B
(59)
Ruxolitinib
T-Cell Non-Hodgkin Lymphoma
Jonathan Brammer
P2
B
(59)
Ruxolitinib
T-Cell Prolymphocytic Leukemia
Jonathan Brammer
P2
B
(59)
Sirolimus
Chronic Myelomonocytic Leukemia
City of Hope Medical Center
P2
B
(59)
Sirolimus
Epilepsy
Xuanwu Hospital, Beijing
P2
B
(59)
Sirolimus
Myelofibrosis
Masonic Cancer Center, University of Minnesota
P2
B
(59)
Sirolimus
Sickle Cell Disease
St. Jude Children's Research Hospital
P2
B
(59)
Tafasitamab
High Grade B-Cell Lymphoma
Brown University
P2
B
(59)
Tafasitamab
Non-Hodgkin Lymphoma
Paolo Caimi, MD
P2
B
(59)
Talazoparib
Refractory Malignant Neoplasm
St. Jude Children's Research Hospital
P2
B
(59)
Talazoparib
Gastric Cancer
National Cancer Institute (NCI)
P2
B
(59)
Talazoparib
Small Cell Lung Carcinoma
University Health Network, Toronto
P2
B
(59)
Showing 2426 to 2450 of 13,155 assets
Previous
Page 98 of 527
Next